Lazard Keeps Emulex (ELX) at Buy; Stagnant Core Markets Causing Shift in Focus

September 20, 2013 10:55 AM EDT Send to a Friend
Lazard Capital maintains a Buy rating on Emulex (NYSE: ELX) following an announcement that the company's CFO Rockenbach would be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login